You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Burrows Scott L · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$221.49K
Burrows Scott L Chief Financial Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
SYRE daily price context
Close on/before transaction
$94.93
Aug 3, 2026
First close after public filing
$103.42
Aug 6, 2026
30-day return after filing
-13.96%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,300 shares @ $96.3
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000100
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$825.52K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE Current | Sale | Aug 3, 2026 | $221.49K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Aug 3, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE | Sale | Aug 3, 2026 | $9.71K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Aug 3, 2026 | $108.75K |
| Spyre Therapeutics, Inc. SYRE | Sale | Aug 3, 2026 | $485.57K |